Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibikase Therapeutics (IKT) Other Working Capital Changes (2020 - 2025)

Inhibikase Therapeutics (IKT) has disclosed Other Working Capital Changes for 6 consecutive years, with $52604.0 as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes changed N/A to $52604.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $110517.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $110517.0 for FY2025, 767.68% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was $52604.0 at Inhibikase Therapeutics, down from $65439.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $759312.0 in Q1 2023, with the low at -$1.1 million in Q2 2021.
  • Average Other Working Capital Changes over 5 years is -$126469.3, with a median of -$23684.0 recorded in 2022.
  • The sharpest move saw Other Working Capital Changes crashed 2871.51% in 2021, then soared 589.65% in 2025.
  • Over 5 years, Other Working Capital Changes stood at -$142619.0 in 2021, then skyrocketed by 106.91% to $9859.0 in 2022, then plummeted by 362.27% to -$25857.0 in 2023, then tumbled by 141.28% to -$62389.0 in 2024, then soared by 184.32% to $52604.0 in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at $52604.0, $65439.0, and -$219450.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.